Mönckeberg arteriosclerosis, also known as Mönckeberg sclerosis, is a noninflammatory form of arteriosclerosis that is distinct from traditional atherosclerosis. The condition is characterized by the deposition of calcium salts in the muscular middle layer of the artery wall, the intima-media, without causing blockage of the vessel lumen. This is an age-related degenerative process, but may also occur in certain pathological conditions, such as pseudoxanthoma elasticum and idiopathic arterial calcification of infancy.
PathophysiologyThe clinical significance and etiology of Mönckeberg's arteriosclerosis are not yet fully understood, and its relationship with atherosclerosis and other types of vascular calcification remains controversial.
The exact pathophysiology of Mönckeberg's arteriosclerosis is still unclear; however, studies suggest that the disease is caused by fatty degeneration of smooth muscle cells in the middle layer of the arteries, leading to large masses of hyperplasia and calcification. In special cases, if atherosclerosis exists at the same time, the clinical symptoms will be more obvious. Most of the time, Mönckeberg calcification occurs near the internal elastic lamina and rarely causes changes in calcium metabolism.
Although the clinical significance of Mönckeberg's arteriosclerosis has not yet been determined, some recent studies suggest that it may be linked to metabolic vascular calcification.
Mönckeberg's arteriosclerosis usually does not cause obvious symptoms unless it is combined with other diseases such as atherosclerosis and calcific dermatitis. Even so, its presence leads to a poor prognosis because vascular calcification leads to increased arterial stiffness, elevated pulse pressure, and ultimately damage to the heart and kidneys. This makes it important to differentiate this disorder from giant cell arteritis, and cranial artery biopsy can help differentiate the two.
As the disease progresses, Mönckeberg arteriosclerosis may lead to blood flow obstruction and thrombosis, which in turn may alter blood pressure and cause tissue ischemia.
Mönckeberg arteriosclerosis is more common in older people, especially those over 50 years old. The condition is also being studied for its association with certain diseases, such as diabetes and chronic kidney disease. Mild calcification of the cardiovascular system is a common phenomenon, which is related to calcium-phosphorus metabolism disorders. Vascular smooth muscle cells secrete hydroxyapatite, which further leads to calcification.
Although the pathogenesis of Mönckeberg's arteriosclerosis is not fully understood, its early stages may be related to vascular gene mutations.
Because Mönckeberg arteriosclerosis is often associated with other diseases, misdiagnosis or delays in the diagnosis process are likely to occur. Clinical examination, X-ray, and ultrasound are common screening methods. However, early detection remains challenging due to the low specificity of the disease and the fact that only a small number of patients present with obvious symptoms.
Currently, specific treatment guidelines do not exist, and potential medical treatments and management options are still under investigation.
Because our understanding of Mönckeberg's arteriosclerosis is still incomplete, future research will focus on clarifying its pathogenesis and seeking effective treatments. Some promising studies have proposed using 3D printed structures to mimic human blood vessels, which may open new doors for treating the disease.
As this prospect advances, we can't help but ask: Will there be a day when this difficult-to-identify disease can be fully cracked, allowing patients to receive the treatment they deserve earlier?